Leo Cancer Care’s $25.3 Million Series B Financing

Wilson Sonsini Goodrich & Rosati advised Leo Cancer Care on the deal.

Leo Cancer Care, an innovative start-up that is set to change the face of radiation therapy forever, announced that it recently completed a $25.3 million Series B fundraise. In addition to lead investor Pureland Global Venture, the largest investors in the round included Yu Galaxy, WARF, Alumni Ventures, Junson Capital, and Serra Ventures, as well as industry leaders CHC, Toret Devices, and Radiation Business Solutions.

The proceeds from the Series B will support Leo Cancer Care as it continues to develop its state-of-the-art upright radiotherapy solutions, which offer significant improvements to clinical effectiveness and patient experience. The company, which is based in Horley, United Kingdom, and Middleton, Wisconsin, also plans to expand its teams in the United States, Europe, and Singapore.

The Wilson Sonsini team that advised Leo Cancer Care on the financing includes James Huie (Picture), Dan Glazer, Patricia Swen, and Jordan Franks.

Involved fees earner: Daniel Glazer – Wilson Sonsini Goodrich & Rosati; James Huie – Wilson Sonsini Goodrich & Rosati; Patricia Swen – Wilson Sonsini Goodrich & Rosati;

Law Firms: Wilson Sonsini Goodrich & Rosati;

Clients: Leo Cancer Care;

Author: Martina Bellini